Work

Impact of immunotherapy infusion timing on overall and progression-free survival in advanced NSCLC.

Year: 2026

Type: conference-abstract

Study design: Observational Study

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2026.44.16_suppl.e20573

Authors: Eduardo Richardet, Nicolas Hitoshi Higa Tamashiro, Santos Depetris, Marcos Lionel Ledesma, Pablo Perea, Martin Eduardo Richardet, Matias Molina

Institution: Instituto Oncológico de Córdoba

Language: English

Topic: Cancer Immunotherapy and Biomarkers

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7162690263

Cites:

Cited by:

Related to: